TACT IP LLC has a total of 11 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are YI QING, CUBIST PHARMACEUTICALS LLC and EMERGO THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Tobinick Edward L | 7 |
#2 | Tobinick Edward Lewis | 4 |
Publication | Filing date | Title |
---|---|---|
AU2015224443A1 | Methods for treatment of brain injury utilizing biologics | |
US2013022540A1 | Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers | |
EP2635283A2 | Methods for treatment of brain injury utilizing biologics | |
US2009130019A1 | Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals | |
US2006009450A1 | Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection | |
US6982089B2 | Cytokine antagonists for neurological and neuropsychiatric disorders |